Standout Papers
- Hepatitis C virus markers in patients with long‐term biochemical and histological remission of chronic hepatitis (1994)
- Evaluation of Hepatitis C Virus Glycoprotein E2 for Vaccine Design: an Endoplasmic Reticulum-Retained Recombinant Protein Is Superior to Secreted Recombinant Protein and DNA-Based Vaccine Candidates (2000)
- Induction of Broad CD4+and CD8+T-Cell Responses and Cross- Neutralizing Antibodies against Hepatitis C Virus by Vaccination with Th1-Adjuvanted Polypeptides Followed by Defective Alphaviral Particles Expressing Envelope Glycoproteins gpE1 and gpE2 and Nonstructural Proteins 3, 4, and 5 (2008)
- Towards a vaccine for the prevention of hepatitis delta virus superinfection in HBV carriers. (1993)
- Antibody response to core, envelope and nonstructural hepatitis C virus antigens: Comparison of immunocompetent and immunosuppressed patients (1993)
- Intrahepatic Genetic Inoculation of Hepatitis C Virus RNA Confers Cross-Protective Immunity (2001)
- Prospects for prophylactic and therapeutic hepatitis C virus vaccines. (1995)
- Expression, identification and subcellular localization of the proteins encoded by the hepatitis C viral genome (1993)
- A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells. (1996)
- Hepatitis C virus envelope glycoprotein immunization of rodents elicits cross-reactive neutralizing antibodies (2007)
- Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults (2010)
- Long-term follow-up of patients with chronic hepatitis C treated with different doses of interferon-α2b (1993)
- Characterization of Hepatitis C Virus Core-Specific Immune Responses Primed in Rhesus Macaques by a Nonclassical ISCOM Vaccine (2001)
- Hepatitis C virus polyprotein vaccine formulations capable of inducing broad antibody and cellular immune responses (2006)
Citation Impact
Citing Papers
HCV Persistence and Immune Evasion in the Absence of Memory T Cell Help
2003 StandoutScienceNobel
Neutralizing antibody response during acute and chronic hepatitis C virus infection
2004 StandoutNobel
Complete Replication of Hepatitis C Virus in Cell Culture
2005 StandoutScienceNobel
Memory CD8 + T Cells Are Required for Protection from Persistent Hepatitis C Virus Infection
2003 StandoutNobel
Mouse models of acute and chronic hepacivirus infection
2017 StandoutScienceNobel
Current progress in development of hepatitis C virus vaccines
2013
Cellular Binding of Hepatitis C Virus Envelope Glycoprotein E2 Requires Cell Surface Heparan Sulfate
2003
Viral and Cellular Determinants of the Hepatitis C Virus Envelope-Heparan SulfateInteraction
2006
Long term response to interferon treatment in chronic hepatitis C patients is associated with a significant reduction in anti-E1 envelope antibody titers
2000
Decreased diversity of hepatitis C virus quasispecies during bone marrow transplantation
1999
Early antibody response against hypervariable region 1 is associated with acute self-limiting infections of hepatitis C virus
1997
SEC14L2 enables pan-genotype HCV replication in cell culture
2015 StandoutNatureNobel
Comprehensive Analyses of CD8+ T Cell Responses During Longitudinal Study of Acute Human Hepatitis C *
2005
Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region
1993
Induction of antibodies against structural proteins of hepatitis C virus in mice using recombinant adenovirus
1996
Completion of the entire hepatitis C virus life cycle in genetically humanized mice
2013 StandoutNatureNobel
Subcellular localization of hepatitis C viral proteins in mammalian cells
1999
Humoral Immune Response in Acute Hepatitis C Virus Infection
2005
The entire nucleotide sequence and classification of a hepatitis C virus isolate of a novel genotype from an Indonesian patient with chronic liver disease
1994
Unravelling hepatitis C virus replication from genome to function
2005 StandoutNatureNobel
Seroreactivity and Genomic Amplification Profile of Hepatitis C Virus From Patients With Chronic Liver Disease in India
1994
Binding of the hepatitis C virus envelope protein E2 to CD81 provides a co-stimulatory signal for human T cells
2001
A model for the hepatitis C virus envelope glycoprotein E2
2000
Prospects for prophylactic and therapeutic vaccines against the hepatitis C viruses
2010 StandoutNobel
Clinical Outcomes after Transfusion-Associated Hepatitis C
1995
Structural Features of Envelope Proteins on Hepatitis C Virus-like Particles as Determined by Anti-envelope Monoclonal Antibodies and CD81 Binding
2002
Cultivation of hepatitis C virus in primary hepatocyte culture from patients with chronic hepatitis C results in release of high titre infectious virus
1996
An infectious molecular clone of a Japanese genotype 1b hepatitis C virus
1999
Vaccination of Chimpanzees With Plasmid DNA Encoding the Hepatitis C Virus (HCV) Envelope E2 Protein Modified the Infection After Challenge With Homologous Monoclonal HCV
2000
Evidence That Hepatitis C Virus Resistance to Interferon Is Mediated through Repression of the PKR Protein Kinase by the Nonstructural 5A Protein
1997
Hepatitis C virus entry: Molecular biology and clinical implications
2006
Synthesis of a novel hepatitis C virus protein by ribosomal frameshift
2001
Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge
2007
Mother-to-child transmission of a hepatitis C virus variant with an insertional mutation in its hypervariable region
1996
The NS3/4A proteinase of the hepatitis C virus: unravelling structure and function of an unusual enzyme and a prime target for antiviral therapy
1999
Effect of Immune Globulin on the Prevention of Experimental Hepatitis C Virus Infection
1996
Cell Culture Models and Animal Models of Viral Hepatitis. Part II: Hepatitis C
2005
Elicitation of strong immune responses by a DNA vaccine expressing a secreted form of hepatitis C virus envelope protein E2 in murine and porcine animal models
2006
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Molecular biology of the hepatitis C virus
1994
Immunopathogenesis of HCV Infection
1998
Cellular glycosaminoglycans and low density lipoprotein receptor are involved in hepatitis C virus adsorption
2002
Protective Immune Response to Hepatitis C Virus in Chimpanzees Rechallenged Following Clearance of Primary Infection
2001 StandoutNobel
Characterization of Human Monoclonal Antibodies Specific to the Hepatitis C Virus Glycoprotein E2 within VitroBinding Neutralization Properties
1998
Prospects for a vaccine against the hepatitis C virus
2005 StandoutNatureNobel
High titers of antibodies inhibiting the binding of envelope to human cells correlate with natural resolution of chronic hepatitis C
1998 StandoutNobel
Molecular Characterization of Hepatitis C Virus
1998 StandoutNobel
Efficient hepatitis C virus particle formation requires diacylglycerol acyltransferase-1
2010
Hepatitis C virus NS4A and NS4B proteins suppress translation in vivo
2001
Vaccine-Induced Cross-Genotype Reactive Neutralizing Antibodies Against Hepatitis C Virus
2011 StandoutNobel
The Humoral Immune Response to HCV: Understanding is Key to Vaccine Development
2014
The ins and outs of hepatitis C virus entry and assembly
2013 StandoutNobel
Clearance of hepatitis C infection is associated with the early appearance of broad neutralizing antibody responses
2014
Analysis of a Successful Immune Response against Hepatitis C Virus
1999 StandoutNobel
Human occludin is a hepatitis C virus entry factor required for infection of mouse cells
2009 StandoutNatureNobel
Nomenclature and Numbering of the Hepatitis C Virus
2009
Characterization of host‐range and cell entry properties of the major genotypes and subtypes of hepatitis C virus†
2005
Folding and dimerization of hepatitis C virus E1 and E2 glycoproteins in stably transfected CHO cells
2005 StandoutNobel
Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry
2007 StandoutNatureNobel
A diverse range of gene products are effectors of the type I interferon antiviral response
2011 StandoutNatureNobel
Global control of hepatitis C: where challenge meets opportunity
2013
Characterization of the hepatitis C virus E2 epitope defined by the broadly neutralizing monoclonal antibody AP33
2006
Hepatitis C Virus Nonstructural Protein NS4B Transforms NIH3T3 Cells in Cooperation with the Ha-ras Oncogene
2000
Full-length Sequence of the Genome of Hepatitis C Virus Type 3a: Comparative Study With Different Genotypes
1994
The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus
2002
Structure of the zinc-binding domain of an essential component of the hepatitis C virus replicase
2005 StandoutNatureNobel
Animal Models for Hepatitis C
2013
Sustained E2 antibody response correlates with reduced peak viremia after hepatitis C virus infection in the chimpanzee†
2005
Recovery, Persistence, and Sequelae in Hepatitis C Virus Infection: A Perspective on Long-Term Outcome
2000
Characterization of Pseudotype VSV Possessing HCV Envelope Proteins
2001
Immune Response to Epitopes of Hepatitis C Virus (HCV) Structural Proteins in HCV-Infected Humans and Chimpanzees
1996
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
2014 Standout
Hepatitis C virus infection: when silence is deception
2003
Characterization of the nuclear localization signal and subcellular distribution of hepatitis C virus nonstructural protein NS5A
1996
Antibody response to E2/NS1 hepatitis C virus protein in patients with acute hepatitis C
1997
Hepatitis C therapeutics: current status and emerging strategies
2002
A Hepatitis C Virus (HCV) Vaccine Comprising Envelope Glycoproteins gpE1/gpE2 Derived from a Single Isolate Elicits Broad Cross-Genotype Neutralizing Antibodies in Humans
2013 StandoutNobel
Hepatitis C virus: why do we need a vaccine to prevent a curable persistent infection?
2015
Clearance of Genotype 1b Hepatitis C Virus in Chimpanzees in the Presence of Vaccine-Induced E1-Neutralizing Antibodies
2011
A genetically humanized mouse model for hepatitis C virus infection
2011 StandoutNatureNobel
Transmission in vitro of hepatitis C virus from persistently infected human B-cells to hepatoma cells by cell-to-cell contact
2005
Comparative features of hepatitis C virus infection in humans and chimpanzees
1997
Novel Insights into Hepatitis C Virus Replication and Persistence
2004
A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees
2006
The way forward in HCV treatment — finding the right path
2007 StandoutNobel
New therapeutic strategies for hepatitis C
2002 StandoutNobel
Limited humoral immunity in hepatitis C virus infection
1999
Replication of hepatitis C virus
2007 StandoutNobel
A critical role for the chimpanzee model in the study of hepatitis C†
2004
Selective Stimulation of Hepatitis C Virus and Pestivirus NS5B RNA Polymerase Activity by GTP
1999
Analysis of Antigenicity and Topology of E2 Glycoprotein Present on Recombinant Hepatitis C Virus-Like Particles
2002
Cellular immune selection with hepatitis C virus persistence in humans
2005
Hepatitis C Virus RNA Replication Occurs on a Detergent-Resistant Membrane That Cofractionates with Caveolin-2
2003
Analysis of Hepatitis C Virus-Inoculated Chimpanzees Reveals Unexpected Clinical Profiles
1998
NS5A, a nonstructural protein of hepatitis C virus, binds growth factor receptor-bound protein 2 adaptor protein in a Src homology 3 domain/ligand-dependent manner and perturbs mitogenic signaling
1999
Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primates
2011 StandoutNobel
Transfection of a differentiated human hepatoma cell line (Huh7) with in vitro-transcribed hepatitis C virus (HCV) RNA and establishment of a long-term culture persistently infected with HCV
1995 StandoutNobel
Flying Under the Radar: The Immunobiology of Hepatitis C
2006 StandoutNobel
Functional Analysis of Cell Surface-Expressed Hepatitis C Virus E2 Glycoprotein
1999
Amphipathic Helix-Dependent Localization of NS5A Mediates Hepatitis C Virus RNA Replication
2003 StandoutNobel
Replication of hepatitis C virus
2000
Characterization of truncated forms of hepatitis C virus glycoproteins.
1997 StandoutNobel
Definition of a Conserved Immunodominant Domain on Hepatitis C Virus E2 Glycoprotein by Neutralizing Human Monoclonal Antibodies
2008
The dynamics of hepatitis C virus binding to platelets and 2 mononuclear cell lines
2001
Binding of Hepatitis C Virus to CD81
1998 StandoutScienceNobel
The NS2 protein of hepatitis C virus is a transmembrane polypeptide
1995
Blocking Hepatitis C Virus Infection with Recombinant Form of Envelope Protein 2 Ectodomain
2009
Processing in the hepatitis C virus E2-NS2 region: identification of p7 and two distinct E2-specific products with different C termini
1994 StandoutNobel
Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors
2013 StandoutScienceNobel
Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization.
1994
Human Monoclonal Antibodies That React With the E2 Glycoprotein of Hepatitis C Virus and Possess Neutralizing Activity *
2005
Recombinant Hepatitis C Virus Envelope Glycoprotein Vaccine Elicits Antibodies Targeting Multiple Epitopes on the Envelope Glycoproteins Associated with Broad Cross-Neutralization
2014 StandoutNobel
A second hepatitis C virus-encoded proteinase.
1993 StandoutNobel
Functional Role of Hepatitis C Virus Chimeric Glycoproteins in the Infectivity of Pseudotyped Virus
1998
Analysis of N-terminal processing of hepatitis C virus nonstructural protein 2
1994
Complex formation between the NS3 serine-type proteinase of the hepatitis C virus and NS4A and its importance for polyprotein maturation
1995
Development of prophylactic and therapeutic vaccines against hepatitis C virus
2005
Formation and intracellular localization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia and Sindbis viruses
1994 StandoutNobel
Monoclonal Antibody AP33 Defines a Broadly Neutralizing Epitope on the Hepatitis C Virus E2 Envelope Glycoprotein
2005
Biochemical properties of hepatitis C virus NS5B RNA-dependent RNA polymerase and identification of amino acid sequence motifs essential for enzymatic activity
1997
Topology of the Membrane-Associated Hepatitis C Virus Protein NS4B
2003
Characterization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia viruses
1993 StandoutNobel
Peptide immunogen mimicry of putative E1 glycoprotein-specific epitopes in hepatitis C virus
1994 StandoutNobel
Isolation and Characterization of Broadly Neutralizing Human Monoclonal Antibodies to the E1 Glycoprotein of Hepatitis C Virus
2007
Previously Infected and Recovered Chimpanzees Exhibit Rapid Responses That Control Hepatitis C Virus Replication upon Rechallenge
2002 StandoutNobel
Hepatitis C virus glycoprotein folding: disulfide bond formation and association with calnexin
1996 StandoutNobel
An N-Terminal Amphipathic Helix in Hepatitis C Virus (HCV) NS4B Mediates Membrane Association, Correct Localization of Replication Complex Proteins, and HCV RNA Replication
2004 StandoutNobel
Efficient Initiation of HCV RNA Replication in Cell Culture
2000 StandoutScienceNobel
Analysis of Antigenicity and Topology of E2 Glycoprotein Present on Recombinant Hepatitis C Virus-Like Particles
2002
Neutralizing antibodies to hepatitis C virus (HCV) in immune globulins derived from anti-HCV-positive plasma
2004
Recombinant human monoclonal antibodies against different conformational epitopes of the E2 envelope glycoprotein of hepatitis C virus that inhibit its interaction with CD81
2000 StandoutNobel
Broadly neutralizing human monoclonal antibodies to the hepatitis C virus E2 glycoprotein
2008
Hepatitis C virus entry: potential receptors and their biological functions
2006
At least 12 genotypes of hepatitis C virus predicted by sequence analysis of the putative E1 gene of isolates collected worldwide.
1993
The Outcome of Acute Hepatitis C Predicted by the Evolution of the Viral Quasispecies
2000 Science
Analysis of a Highly Flexible Conformational Immunogenic Domain A in Hepatitis C Virus E2
2005
Binding of Hepatitis C Virus-Like Particles Derived from Infectious Clone H77C to Defined Human Cell Lines
2002
Characterization of hepatitis C virus replication in cloned cells obtained from a human T-cell leukemia virus type 1-infected cell line, MT-2
1996
Viral Persistence, Antibody to E1 and E2, and Hypervariable Region 1 Sequence Stability in Hepatitis C Virus-Inoculated Chimpanzees
1999
Proteolytic processing and membrane association of putative nonstructural proteins of hepatitis C virus.
1993
Kinetics of CD4+and CD8+Memory T-Cell Responses during Hepatitis C Virus Rechallenge of Previously Recovered Chimpanzees
2003 StandoutNobel
CD81 Is a Central Regulator of Cellular Events Required for Hepatitis C Virus Infection of Human Hepatocytes
2008
Cell Fusion Activity of Hepatitis C Virus Envelope Proteins
2000
Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus
1993
Hepatitis C Virus Structural Proteins Assemble into Viruslike Particles in Insect Cells
1998
Cross-Genotype Immunity to Hepatitis C Virus
2004
Kinetic and structural analyses of hepatitis C virus polyprotein processing
1994
Human Monoclonal Antibodies That Inhibit Binding of Hepatitis C Virus E2 Protein to CD81 and Recognize Conserved Conformational Epitopes
2000
Pathogenesis, Natural History, Treatment, and Prevention of Hepatitis C
2000
Dynamic analysis of hepatitis C virus replication and quasispecies selection in long-term cultures of adult human hepatocytes infected in vitro
1999
Neutralizing Monoclonal Antibodies against Hepatitis C Virus E2 Protein Bind Discontinuous Epitopes and Inhibit Infection at a Postattachment Step
2011
Interaction between hepatitis C virus core protein and E1 envelope protein
1996
Detection and Distribution of Hepatitis C—Specific Antigens in Naturally Infected Liver
1994
The Native Form and Maturation Process of Hepatitis C Virus Core Protein
1998
Mapping B-Cell Epitopes of Hepatitis C Virus E2 Glycoprotein Using Human Monoclonal Antibodies from Phage Display Libraries
2001
Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses: proposals for standardization
1998
Identification of the sequence on NS4A required for enhanced cleavage of the NS5A/5B site by hepatitis C virus NS3 protease
1996
Human Serum Facilitates Hepatitis C Virus Infection, and Neutralizing Responses Inversely Correlate with Viral Replication Kinetics at the Acute Phase of Hepatitis C Virus Infection
2005
Activation of naïve B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders
2005 StandoutNobel
A Point Mutation Leading to Hepatitis C Virus Escape from Neutralization by a Monoclonal Antibody to a Conserved Conformational Epitope
2008
Hepatitis C Virus Glycoproteins Interact with DC-SIGN and DC-SIGNR
2003 StandoutNobel
Two hepatitis C virus glycoprotein E2 products with different C termini
1994
Folding of Hepatitis C Virus E1 Glycoprotein in a Cell-Free System
2001 StandoutNobel
Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV
1993 StandoutNobel
The dynamics of hepatitis C virus binding to platelets and 2 mononuclear cell lines
2001
Structure-Function Analysis of Hepatitis C Virus Envelope-CD81 Binding
2000 StandoutNobel
Mutations in Hepatitis C Virus E2 Located outside the CD81 Binding Sites Lead to Escape from Broadly Neutralizing Antibodies but Compromise Virus Infectivity
2009 StandoutNobel
Activation of the grp78 and grp94 Promoters by Hepatitis C Virus E2 Envelope Protein
1999 StandoutNobel
Different Domains of CD81 Mediate Distinct Stages of Hepatitis C Virus Pseudoparticle Entry
2006
Hepatitis C virus lacking the hypervariable region 1 of the second envelope protein is infectious and causes acute resolving or persistent infection in chimpanzees
2000
Characterization of Hepatitis C Virus E2 Glycoprotein Interaction with a Putative Cellular Receptor, CD81
1999
Structural basis of hepatitis C virus neutralization by broadly neutralizing antibody HCV1
2012
Functional Characterization of Intracellular and Secreted Forms of a Truncated Hepatitis C Virus E2 Glycoprotein
2000
Biosynthesis and biochemical properties of the hepatitis C virus core protein
1994
Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein
1996
Limited T Cell Receptor Diversity of HCV-specific T Cell Responses Is Associated with CTL Escape
2004
Hepatitis C virus infection associated with administration of intravenous immune globulin. A cohort study.
1996
Transfection of HepG2 cells with infectious hepatitis C virus genome.
1997
Direct interaction of hepatitis C virus core protein with the cellular lymphotoxin-beta receptor modulates the signal pathway of the lymphotoxin-beta receptor
1997
Binding of the Hepatitis C Virus E2 Glycoprotein to CD81 Is Strain Specific and Is Modulated by a Complex Interplay between Hypervariable Regions 1 and 2
2003
Previously Infected Chimpanzees Are Not Consistently Protected against Reinfection or Persistent Infection after Reexposure to the Identical Hepatitis C Virus Strain
2008
Evidence for Protection against Chronic Hepatitis C Virus Infection in Chimpanzees by Immunization with Replicating Recombinant Vaccinia Virus
2008
A Natural Intergenotypic Recombinant of Hepatitis C Virus Identified in St. Petersburg
2002
Structure of the catalytic domain of the hepatitis C virus NS2-3 protease
2006 StandoutNatureNobel
Liver-Derived CTL in Hepatitis C Virus Infection: Breadth and Specificity of Responses in a Cohort of Persons with Chronic Infection
1998 StandoutNobel
Sexual transmission of the hepatitis C virus and efficacy of prophylaxis with intramuscular immune serum globulin. A randomized controlled trial.
1997
Works of David Chien being referenced
Hepatitis C virus envelope glycoprotein immunization of rodents elicits cross-reactive neutralizing antibodies
2007 StandoutNobel
Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults
2010 StandoutNobel
Hepatitis C virus markers in patients with long‐term biochemical and histological remission of chronic hepatitis
1994 StandoutNobel
Expression, identification and subcellular localization of the proteins encoded by the hepatitis C viral genome
1993 StandoutNobel
Prospective Evaluation of Community‐Acquired Acute‐Phase Hepatitis C Virus Infection
2005
Induction of Broad CD4+and CD8+T-Cell Responses and Cross- Neutralizing Antibodies against Hepatitis C Virus by Vaccination with Th1-Adjuvanted Polypeptides Followed by Defective Alphaviral Particles Expressing Envelope Glycoproteins gpE1 and gpE2 and Nonstructural Proteins 3, 4, and 5
2008 StandoutNobel
Evaluation of Hepatitis C Virus Glycoprotein E2 for Vaccine Design: an Endoplasmic Reticulum-Retained Recombinant Protein Is Superior to Secreted Recombinant Protein and DNA-Based Vaccine Candidates
2000 StandoutNobel
At least five related, but distinct, hepatitis C viral genotypes exist.
1992
Evidence for hepatitis C viral infection in patients with primary hepatocellular carcinoma.
1994
Prospects for prophylactic and therapeutic hepatitis C virus vaccines.
1995 StandoutNobel
Vaccination of chimpanzees against infection by thehepatitis C virus.
1994
A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells.
1996 StandoutNobel
Antibody response to core, envelope and nonstructural hepatitis C virus antigens: Comparison of immunocompetent and immunosuppressed patients
1993 StandoutNobel
Evaluation of a novel serotyping system for hepatitis C virus: strong correlation with standard genotyping methodologies
1995
Intrahepatic Genetic Inoculation of Hepatitis C Virus RNA Confers Cross-Protective Immunity
2001 StandoutNobel
Lack of antibodies to the envelope glycoproteins of hepatitis C virus in immunoglobulin preparations from screened donors.
1996 Nobel
Characterization of Hepatitis C Virus Core-Specific Immune Responses Primed in Rhesus Macaques by a Nonclassical ISCOM Vaccine
2001 StandoutNobel